TransCode Therapeutics sets July 2, 2026 annual meeting; proposal deadline June 11

Transcode Therapeutics, Inc.

Annual meeting scheduled for July 2, 2026; record date May 28, 2026.
Stockholder proposals for proxy inclusion due by June 11, 2026 (5:00 p.m. ET).
Director nominations and other business notices also due by June 11, 2026.
Meeting date moved more than 30 days from 2025 annual meeting (Aug 29, 2025).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.